Ghana has joined an €11 million international project to combat dengue fever in sub-Saharan Africa.
The initiative, called Project DENSTAR, involves global research institutions and will test a new single-dose vaccine, DengiAll, in advanced Phase III clinical trials. The project, which began on June 1, 2026, aims to improve disease prevention in Africa, where dengue cases are rising due to climate change and urbanization.
Kwame Nkrumah University of Science and Technology (KNUST) in Ghana will host these trials, placing the country at the center of global research to combat this mosquito-borne disease.
